The Oncosearch | Oncotarget

Impact of cell fusion in myeloma marrow microenvironment on tumor progression Research Paper

Ziyan Wang, Yuqing Yuan, Liying Zhang, Zhou Min, Dongming Zhou, Sun Yu, Panjun Wang, Songguang Ju, Li Jun, Jinxiang Fu

Published Jul 24, 2018 · Vol. 9, No. 57 · pp. 30997-31006

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis Research Paper

Dai Chihara, Nathan H. Fowler, Yasuhiro Oki, Michelle A. Fanale, Loretta J. Nastoupil, Jason R. Westin, Luis E. Fayad, Sattva S. Neelapu, Chan Yoon Cheah

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28897-28902

Increased circulating CD4⁺FOXP3⁺ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients Research Paper

Egor V. Batorov, Marina A. Tikhonova, Natalia V. Pronkina, Irina V. Kryuchkova, Vera V. Sergeevicheva, Svetlana A. Sizikova, Galina Y. Ushakova, Tatiana A. Aristova, Dariya S. Batorova, Elena V. Menyaeva, Andrey V. Gilevich, Ekaterina Y. Shevela, Alexander A. Ostanin, Elena R. Chernykh

Published Jun 5, 2018 · Vol. 9, No. 43 · pp. 27305-27317

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma Research Paper

De-Xiu Bu, Reshma Singh, Eugene E. Choi, Marco Ruella, Selene Nunez-Cruz, Keith G. Mansfield, Paul Bennett, Nathanial Barton, Qilong Wu, Jiquan Zhang, Yongqiang Wang, Lai Wei, Shawn Cogan, Tucker Ezell, Shree Joshi, Kellie J. Latimer, Brian Granda, William R. Tschantz, Regina M. Young, Heather A. Huet, Celeste J. Richardson, Michael C. Milone

Published May 25, 2018 · Vol. 9, No. 40 · pp. 25764-25780

Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death Research Paper

Christian Argueta, Trinayan Kashyap, Boris Klebanov, Thaddeus J. Unger, Cathy Guo, Susie Harrington, Erkan Baloglu, Margaret Lee, William Senapedis, Sharon Shacham, Yosef Landesman

Published May 22, 2018 · Vol. 9, No. 39 · pp. 25529-25544

High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma Research Paper

Soushi Ibata, Masayoshi Kobune, Shohei Kikuchi, Masahiro Yoshida, Shogo Miura, Hiroto Horiguchi, Kazuyuki Murase, Satoshi Iyama, Kohichi Takada, Koji Miyanishi, Junji Kato

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25127-25135

Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients Research Paper

Markus Wennmann, Laurent KintzelÃ©, Marie Piraud, Bjoern H. Menze, Thomas Hielscher, Johannes Hofmanninger, Barbara Wagner, Hans-Ulrich Kauczor, Maximilian Merz, Jens Hillengass, Georg Langs, Marc-AndrÃ© Weber

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25254-25264

The B cell receptor signaling pathway in mantle cell lymphoma Review

Maria I. Merolle, Makhdum Ahmed, Krystle Nomie, Michael L. Wang

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25332-25341

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients Research Paper

Aneta Szudy-Szczyrek, RadosÅ‚aw Mlak, MichaÅ‚ Szczyrek, Sylwia Chocholska, Jacek Sompor, Adam Nogalski, Teresa MaÅ‚ecka-Massalska, Marek Hus

Published May 8, 2018 · Vol. 9, No. 35 · pp. 24054-24068

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Guillemette Fouquet, StÃ©phanie Guidez, Valentine Richez, Anne-Marie Stoppa, Christophe Le Tourneau, Margaret Macro, CÃ©cile Gruchet, Arthur Bobin, Niels Moya, Thomas Systchenko, Florence Sabirou, Anthony Levy, Paul Franques, HÃ©lÃ¨ne Gardeney, Lionel Karlin, Lotfi Benboubker, Monia Ouali, Jean-Claude Vedovato, Pierre Ferre, Mariya Pavlyuk, Michel Attal, Thierry Facon, Xavier Leleu

Published May 8, 2018 · Vol. 9, No. 35 · pp. 23890-23899

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials Meta-Analysis

Chintan Shah, Rohit Bishnoi, Yu Wang, Fei Zou, Harini Bejjanki, Samip Master, Jan S. Moreb

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23704-23717

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells Correction

Nathan De Beule, Eline Menu, Mathieu J.M. Bertrand, MÃ©rÃ©dis Favreau, Elke De Bruyne, Ken Maes, Kim De Veirman, Magdalena Radwanska, Afshin Samali, Stefan Magez, Karin Vanderkerken, Carl De Trez

Published Apr 27, 2018 · Vol. 9, No. 32 · pp. 22871-22871

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes Research Paper

Taylor Harding, Jessica Swanson, Brian Van Ness

Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 21930-21942

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation Research Paper

Karel Fostier, Jo Caers, Nathalie Meuleman, Katrijn Broos, Jurgen Corthals, Kris Thielemans, Rik Schots, Brenda De Keersmaecker

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20476-20489

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma Research Paper

Aurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, Maria Antonia Frassanito, Patrizia Leone, Vito Racanelli, Beatrice Nico, Domenico Ribatti, Paolo Ditonno, Marcella Prete, Antonio Giovanni Solimando, Francesco Dammacco, Angelo Vacca, Roberto Ria

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20563-20577

Mouse models of multiple myeloma: technologic platforms and perspectives Review

Marco Rossi, Cirino Botta, Mariamena Arbitrio, Rosa Daniela Grembiale, Pierosandro Tagliaferri, Pierfrancesco Tassone

Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 20119-20133

Cold atmospheric plasma as a potential tool for multiple myeloma treatment Research Paper

Dehui Xu, Yujing Xu, Qingjie Cui, Dingxin Liu, Zhijie Liu, Xiaohua Wang, Yanjie Yang, Miaojuan Feng, Rong Liang, Hailan Chen, Kai Ye, Michael G. Kong

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18002-18017

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Sena, Hong Wu, Aiping Dong, Hong Zeng, Fengling Li, Renato Ferreira de Freitas, Mohammad S. Eram, Matthieu Schapira, Yuji Baba, Mihoko Kunitomo, Douglas R. Cary, Michiko Tawada, Akihiro Ohashi, Yasuhiro Imaeda, Kumar Singh Saikatendu, Charles E. Grimshaw, Masoud Vedadi, Cheryl H. Arrowsmith, Dalia Barsyte-Lovejoy, Atsushi Kiba, Daisuke Tomita, Peter J. Brown

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18480-18493

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent Research Paper

Eleni-Dimitra Papanagnou, Evangelos Terpos, Efstathios Kastritis, Issidora S. Papassideri, Ourania E. Tsitsilonis, Meletios A. Dimopoulos, Ioannis P. Trougakos

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17797-17809

Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years Research Paper

Louis Jacob, Moritz Freyn, Matthias Kalder, Konstantinos Dinas, Karel Kostev

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17420-17429

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Impact of cell fusion in myeloma marrow microenvironment on tumor progression Research Paper

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis Research Paper

Increased circulating CD4⁺FOXP3⁺ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients Research Paper

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma Research Paper

Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death Research Paper

High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma Research Paper

Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients Research Paper

The B cell receptor signaling pathway in mantle cell lymphoma Review

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients Research Paper

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials Meta-Analysis

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells Correction

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes Research Paper

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation Research Paper

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma Research Paper

Mouse models of multiple myeloma: technologic platforms and perspectives Review

Cold atmospheric plasma as a potential tool for multiple myeloma treatment Research Paper

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent Research Paper

Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Impact of cell fusion in myeloma marrow microenvironment on tumor progression Research Paper

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis Research Paper

Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients Research Paper

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma Research Paper

Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death Research Paper

High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma Research Paper

Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients Research Paper

The B cell receptor signaling pathway in mantle cell lymphoma Review

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients Research Paper

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials Meta-Analysis

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells Correction

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes Research Paper

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation Research Paper

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma Research Paper

Mouse models of multiple myeloma: technologic platforms and perspectives Review

Cold atmospheric plasma as a potential tool for multiple myeloma treatment Research Paper

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent Research Paper

Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years Research Paper

Increased circulating CD4⁺FOXP3⁺ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients Research Paper